Elekta pledges $1 million to support RT research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 5
Volume 18
Issue 5

Elekta has promised $1 million to the Radiation Oncology Institute, a campaign spearheaded by the American Society for Radiation Oncology to raise awareness of radiation therapy.

Elekta has promised $1 million to the Radiation Oncology Institute, a campaign spearheaded by the American Society for Radiation Oncology to raise awareness of radiation therapy.

To date, the institute has raised $7 million of its $10 million goal. ASTRO initially kicked in $5 million that was matched by $3 million from ASTRO members. Other contributors include Varian Medical Systems at $2 million.

The institute will conduct objective research on the specialty to document the value, safety, efficacy and cost effectiveness of radiation therapy, according to Colleen A. Lawton, MD, campaign cochair.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.